TheFiscalFinder
● Single award · contract

Monoclonal Antibody LY-COV555

A single federal award, with both ends of the trail linked.
$1.4B
total award value
2020
action date
8 mo
period
W911QY21C0016
PIID
Agency ›
Department of Defense
✓ from source
awarded→$1.4B
Recipient ›
Eli Lilly and Company
✓ from source
performed in→
State ›
Indiana
✓ from source
Awarding agencyDepartment of Defense →
RecipientEli Lilly and Company →
Place of performanceIndiana →
CategoryNAICS 325412PSC 6505
Competed?Not recorded✓ from source
Total (exact)$1,373,930,000

More awards to Eli Lilly and Company

LYCOV1404 Bebtelovimab
awarded 2022$1.5B
Purchase of a Total of 614,000 Doses of Combination Monoclonal Antibody
awarded 2021$1.3B
Purchase of 388,000 Doses of Monoclonal Antibody LY-COV016
awarded 2021$329.8M
Combination Monoclonal Antibody - Delivery Order for 100,000 Doses
awarded 2021$210M
All awards to this recipient →

More from Department of Defense

Contract HT940216C0001
awarded 2016$51.3B
LRIP Lot 12 Advance Acquisition Contract
awarded 2017$35.1B
SSN 802 and 803 Long Lead Time Material
awarded 2017$34.9B
Contract N0001902C3002
awarded 2001$34.2B
KC-X Modernization Program
awarded 2011$32B
All awards from this agency →
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.